Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
UACC-893
HER2amp
Luminal
GSK1070916
AURK
AURK
9933.001
uM
7.66590
31.25820
-0.0485 -1.0000 0.7817 0.1942
0.8542
0.4544
LY2
HR+
Luminal
FR180204
ERK1/2
MAPK
10816.149
uM
inf
inf
1.0500 1.0500 0.0000 -0.0238
-0.1642
0.4545
LY2
HR+
Luminal
L-779450
BRAF
MAPK
10816.149
uM
inf
inf
1.0500 1.0500 0.0000 -0.0500
-inf
0.4545
BT-483
HR+
Luminal
AG1024
IGF1R
RTK
5908.066
uM
inf
inf
0.0534 0.0534 0.0000 0.3542
0.4565
0.4546
BT-483
HR+
Luminal
Nutlin 3a
MDM2
MDM2
5908.066
uM
1.75580
21.91120
-0.4730 -1.0000 0.4353 0.4147
0.7753
0.4546
HCC2185
TNBC
Luminal
GSK461364
PLK1
PLK
7848.001
uM
0.00690
0.01004
-0.7963 -0.4889 1.8144 0.9258
0.9490
0.4548
HCC2185
TNBC
Luminal
GSK1070916
AURK
AURK
7848.001
uM
0.23168
2.21180
-0.7395 -1.0000 0.4869 0.5192
0.9120
0.4548
HCC2185
TNBC
Luminal
GSK923295
CENPE
Kinesin
7848.001
uM
0.06638
0.07453
-0.5258 -0.3922 5.0000 0.6420
0.9828
0.4548
HCC1395
TNBC
Basal B
Dichloroacetate
PDK
PDK
13538.176
uM
inf
inf
0.8042 0.8042 0.0000 0.1436
0.3146
0.4572
HCC2185
TNBC
Luminal
Bortezomib
Proteasome
Proteasome
7463.074
uM
0.01945
0.03339
-0.9295 -0.8410 1.8261 1.2121
0.9953
0.4574
HCC2185
TNBC
Luminal
Triciribine
AKT
AKT
7463.074
uM
0.00542
0.03653
-0.6802 -0.6973 0.4578 0.8845
0.9924
0.4574
HCC2185
TNBC
Luminal
Etoposide
TOP2
TOP
7463.074
uM
42.50860
61.23060
-0.3217 -0.4060 1.6287 0.2813
0.8396
0.4574
HCC2185
TNBC
Luminal
Bortezomib
Proteasome
Proteasome
7463.074
uM
0.01945
0.03339
-0.9295 -0.8410 1.8261 1.2121
0.9953
0.4574
MDA-MB-175-VII
HR+
Luminal
Gefitinib
EGFR
ErbB
7884.016
uM
0.47631
0.73937
-0.9300 -0.8658 2.2852 0.5216
0.9965
0.4603
MDA-MB-175-VII
HR+
Luminal
AG1478
EGFR
ErbB
7884.016
uM
0.94029
1.49620
-0.9477 -0.9023 2.2201 0.6875
0.9970
0.4603
MDA-MB-175-VII
HR+
Luminal
(Z)-4-Hydroxytamoxifen
ESR1
7884.016
uM
inf
inf
1.0238 1.0238 0.0000 -0.0464
-32.8843
0.4603
UACC-812
HER2amp
Luminal
Trametinib
MEK
MAPK
10150.012
uM
19.17560
17.90770
0.6457 0.1448 5.0000 0.0038
0.7810
0.4611
UACC-812
HER2amp
Luminal
Geldanamycin
HSP90
HSP90
10150.012
uM
0.02042
0.02445
-0.7512 -0.7308 4.9997 1.1335
0.9985
0.4611
HCC1187
TNBC
Basal A
Trametinib
MEK
MAPK
7811.036
uM
4.20720
17.31660
0.0126 -1.0000 0.7765 0.1581
0.9649
0.4612
HCC1395
TNBC
Basal B
Mebendazole
13538.174
uM
0.35354
3.4640
-0.6961 -1.0000 0.4814 0.5295
0.9154
0.4615
HCC1395
TNBC
Basal B
Nelfinavir
13538.174
uM
27.72930
47.49070
0.3603 -0.9028 1.9173 0.0735
0.9481
0.4615
HCC1395
TNBC
Basal B
Disulfiram
Proteasome
Proteasome
13538.174
uM
inf
0.14414
0.6866 0.6441 5.0000 0.1678
0.7406
0.4615
HCC1419
HER2amp
Luminal
Baicalein
Lipoxygenase
Metabolism
7437.073
uM
146.82210
170.80150
0.2612 -0.5653 5.0000 0.0246
0.9617
0.4617
MDA-MB-175-VII
HR+
Luminal
Pemetrexed
TYMS/DHFR/GARFT
TYMS
7500.095
uM
inf
inf
1.0500 1.0500 0.0000 -0.0333
-0.7066
0.4619
MDA-MB-175-VII
HR+
Luminal
Ixabepilone
TUBB
TUBB
7500.095
uM
0.01082
0.57770
-0.9986 -1.0000 0.2762 0.7708
0.6111
0.4619